USF, UF Earn High Worldwide Rankings for Patents
The University of Florida and the University of South Florida ranked among the top 15 schools in the world to be granted U.S. utility patents last year, according to a new report.
Dr. Lampotang Receives J.S. Gravenstein Award From Society for Technology in Anesthesia
Samsun (Sem) Lampotang, Ph.D., FSSH, FAIMBE, has received the prestigious 2022 J.S. Gravenstein Award from the Society for Technology in Anesthesia (STA).
Can Artichoke Become a New Winter Crop in Florida?
Shinsuke Agehara, a UF/IFAS assistant professor of Horticultural Sciences based at the Gulf Coast Research and Education Center (GCREC) in Balm, has been leading research efforts for years into making artichokes less alternative and more mainstream for hungry growers in the Sunshine State.
OncoMyx Announces Exclusive Option to License Intellectual Property Rights for Myxoma Virus Technology from University of Florida
OncoMyx Therapeutics, a privately-held oncolytic immunotherapy company, has extended its intellectual property (IP) portfolio to include an exclusive option to license IP rights for the use and delivery of myxoma virus to treat certain cancers from the University of Florida Research Foundation (UFRF).
Glint Pharmaceuticals Begins Clinical Trials to Treat Corneal Abrasions and Infections
UF startup Glint Pharmaceuticals, an ophthalmic pharmaceutical company that delivers medicated contact lenses to treat eye diseases, announces the start of a phase I safety study to treat corneal infections and superficial injuries.
UF Health Researchers Join Global Effort To Track COVID-19 Pandemic and Others in Future
University of Florida Health researchers are joining an ambitious global effort led by The Rockefeller Foundation to better track the coronavirus and its variants and set up a network of collaborators to stop any nascent pandemic in the future.
Atsena Therapeutics Appoints Kenji Fujita, MD, as Chief Medical Officer
UF startup Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, announced the appointment of Kenji Fujita, MD, to the newly created position of Chief Medical Officer.
Karl LaPan, New UF Innovate Director, Plans Continued Growth, Success for Program
Following a record-breaking year of growth for Alachua’s biotechnology industry, the University of Florida’s programs for entrepreneurial incubation and innovation, UF Innovate, has hired a new director of incubation services who’s looking to continue the program’s upward trajectory.
UF Creates Antibacterial Agents to Help Eradicate Antibiotic-Resistant Bacteria
UF medicinal chemists report promising results from a study focused on new ways to of treating several types of antibiotic-resistant bacteria, advances that may help in the battle against MRSA, tuberculosis and other infectious pathogens.
Phase 3 ePHex Study: OxThera Reports Results
Sid Martin Biotech alum OxThera AB, a biopharma company dedicated to improving the lives of people with Primary Hyperoxaluria (PH), announces results of its pivotal Phase 3 study.
